Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms
Open Access
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 19 (12), 1555-1562
- https://doi.org/10.1038/modpathol.3800679
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Blastic natural killer cell lymphoma/leukemia (CD56‐positive blastic tumor)Cancer, 2005
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Blastic NK-Cell Lymphomas (Agranular CD4+CD56+ Hematodermic Neoplasms)American Journal of Clinical Pathology, 2005
- IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell PrecursorsAnnual Review of Immunology, 2005
- TCL1 and CLA Expression in Agranular CD4/CD56 Hematodermic Neoplasms (Blastic NK-Cell Lymphomas) and Leukemia CutisAmerican Journal of Clinical Pathology, 2004
- Non-B, Non-T Neoplasms With Lymphoblast MorphologyThe American Journal of Surgical Pathology, 2003
- MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast CancerCell, 2003
- CD56+ TdT+ blastic natural killer cell tumor of the skinCancer, 2002
- Phenotypic Characterization of Five Dendritic Cell Subsets in Human TonsilsThe American Journal of Pathology, 2001
- Identification of a leukemic counterpart of the plasmacytoid dendritic cellsBlood, 2001